A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)

MLA

Hayley Prout, et al. “A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically Effective and Cost-Effective Length of Anticoagulation with Low-Molecular-Weight Heparin In the Treatment of Cancer-Associated Thrombosis (ALICAT).” Health Technology Assessment, vol. 19, no. 83, Oct. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44068a6597c6011a1908b4a61f2e501e&authtype=sso&custid=ns315887.

APA

Hayley Prout, Joanna D Smith, Marie-Jet Bekkers, Kerenza Hood, Jessica Baillie, A. T. Cohen, Jessica Evans, Annmarie Nelson, Angela C. Casbard, Simon Noble, Stephanie Sivell, David Cohen, Kate Fletcher, David Fitzmaurice, Joanna Canham, Miriam J. Johnson, & Anthony Maraveyas. (2015). A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment, 19(83).

Chicago

Hayley Prout, Joanna D Smith, Marie-Jet Bekkers, Kerenza Hood, Jessica Baillie, A. T. Cohen, Jessica Evans, et al. 2015. “A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically Effective and Cost-Effective Length of Anticoagulation with Low-Molecular-Weight Heparin In the Treatment of Cancer-Associated Thrombosis (ALICAT).” Health Technology Assessment 19 (83). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44068a6597c6011a1908b4a61f2e501e&authtype=sso&custid=ns315887.